The role of continuous subcutaneous insulin infusion therapy in patients with diabetic gastroparesis

被引：0
|
作者：
D. Sharma
G. Morrison
F. Joseph
T. S. Purewal
P. J. Weston
机构：
[1] The Royal Liverpool University Hospital,
[2] Countess of Chester Hospital NHS Foundation Trust,undefined
来源：
Diabetologia | 2011年 / 54卷
关键词：
CSII; Gastroparesis; Glycaemic instability; Hospital admissions; Insulin pump; Length of stay;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2768 / 2770
页数：2
相关论文
共 50 条
  • [21] THE PHARMACOKINETICS OF INSULIN AFTER CONTINUOUS SUBCUTANEOUS INFUSION OR BOLUS SUBCUTANEOUS INJECTION IN DIABETIC-PATIENTS
    KOBAYASHI, T
    SAWANO, S
    ITOH, T
    KOSAKA, K
    HIRAYAMA, H
    KASUYA, Y
    DIABETES, 1983, 32 (04) : 331 - 336
  • [22] Effects of Insulin Therapy with Continuous Subcutaneous Insulin Infusion (CSII) in Diabetic Patients: Comparison with Multi-daily Insulin Injections Therapy (MDI)
    Derosa, Giuseppe
    Maffioli, Pamela
    D'Angelo, Angela
    Salvadeo, Sibilla A. T.
    Ferrari, Ilaria
    Fogari, Elena
    Mereu, Roberto
    Gravina, Alessia
    Palumbo, Ilaria
    Randazzo, Sabrina
    Cicero, Arrigo F. G.
    ENDOCRINE JOURNAL, 2009, 56 (04) : 571 - 578
  • [23] Combination of continuous subcutaneous infusion of insulin and octreotide in Type 1 diabetic patients
    Bruttomesso, D
    Fongher, C
    Silvestri, B
    Barberio, S
    Marescotti, MC
    Iori, E
    Valerio, A
    Crazzolara, D
    Pianta, A
    Tiengo, A
    Del Prato, S
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2001, 51 (02) : 97 - 105
  • [24] Depression and anxiety symptoms in diabetic patients on continuous subcutaneous insulin infusion (CSII)
    Reichel, A
    Schwarz, J
    Schulze, J
    Licinio, J
    Wong, ML
    Bornstein, SR
    MOLECULAR PSYCHIATRY, 2005, 10 (11) : 975 - 976
  • [25] USE OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION TO ACHIEVE NORMOGLYCEMIA IN DIABETIC-PATIENTS
    PICKUP, JC
    KEEN, H
    PARSONS, JA
    ALBERTI, KGM
    DIABETOLOGIA, 1977, 13 (04) : 425 - 425
  • [26] Depression and anxiety symptoms in diabetic patients on continuous subcutaneous insulin infusion (CSII)
    A Reichel
    J Schwarz
    J Schulze
    J Licinio
    M-L Wong
    S R Bornstein
    Molecular Psychiatry, 2005, 10 : 975 - 976
  • [27] Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study
    Calles-Escandon, Jorge
    Koch, Kenneth L.
    Hasler, William L.
    Van Natta, Mark L.
    Pasricha, Pankaj J.
    Tonascia, James
    Parkman, Henry P.
    Hamilton, Frank
    Herman, William H.
    Basina, Marina
    Buckingham, Bruce
    Earle, Karen
    Kirkeby, Kjersti
    Hairston, Kristen
    Bright, Tamis
    Rothberg, Amy E.
    Kraftson, Andrew T.
    Siraj, Elias S.
    Subauste, Angela
    Lee, Linda A.
    Abell, Thomas L.
    McCallum, Richard W.
    Sarosiek, Irene
    Nguyen, Linda
    Fass, Ronnie
    Snape, William J.
    Vaughn, Ivana A.
    Miriel, Laura A.
    Farrugia, Gianrico
    PLOS ONE, 2018, 13 (04):
  • [28] PHARMACOKINETICS OF INSULIN - IMPLICATIONS FOR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY
    KRAEGEN, EW
    CHISHOLM, DJ
    CLINICAL PHARMACOKINETICS, 1985, 10 (04) : 303 - 314
  • [29] Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps
    Potti, Lakshmi G.
    Haines, Stuart T.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2009, 49 (01) : E1 - E16
  • [30] Review of continuous subcutaneous insulin infusion (insulin pump) therapy
    Chellamuthu, P.
    Lawrence, I. G.
    Kitchener, D.
    McNally, P. G.
    Gregory, R.
    Jackson, S.
    Kong, M. F.
    Davies, M. J.
    DIABETIC MEDICINE, 2008, 25
12345